INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

21,218 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
35
Lizzie FletcherDSelf
MSFTMICROSOFT CORP
Partial sale
SELL$1,001 – $15KApr 8, 2026May 1, 2026
traded Apr 8, 2026
+23dHouse PTR

Evidence

Page 303 of 531
← PrevNext →
35
Lizzie FletcherDSelf
LLYELI LILLY & Co
Partial sale
SELL
$1,001 – $15K
Apr 8, 2026
May 1, 2026
traded Apr 8, 2026
+23d
House PTR

Evidence

34
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Open-market sale · 10b5-1 plan
SELL$1.56M
55.6K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

34
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Open-market sale · 10b5-1 plan
SELL$1.56M
55.6K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

33
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$991K
8,834 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

33
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$883K
7,796 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

33
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$418K
3,754 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

32
CS
Cashman SteveChief Business Officer
BFLYButterfly Network, Inc.
Open-market sale
SELL$724K
147.5K sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

30
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$221K
1,950 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

30
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$248K
2,208 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

30
Lizzie FletcherDSelf
GOOGLAlphabet Inc.
Partial sale
SELL$1,001 – $15KApr 8, 2026May 1, 2026
traded Apr 8, 2026
+23dHouse PTR

Evidence

30
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$105K
939 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

30
Lizzie FletcherDSelf
AAPLApple Inc.
Partial sale
SELL$1,001 – $15KApr 8, 2026May 1, 2026
traded Apr 8, 2026
+23dHouse PTR

Evidence

28
LK
Larabee Brian KeithSVP & GM - EMS
ROGROGERS CORP
Open-market sale
SELL$113K
830 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

28
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$764K
10.4K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

28
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$377K
5,059 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

27
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.39M
19.7K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

27
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.48M
21.3K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$57K
520 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

26
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$112K
8,457 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

26
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$111K
8,458 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

26
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Open-market sale · 10b5-1 plan
SELL$1.33M
47.2K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

26
YM
Young Tobi M.Director
HALHALLIBURTON CO
Open-market sale
SELL$21K
500 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$226K
2,080 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$51K
460 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$190K
1,760 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

26
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$203K
1,840 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

25
SM
Schmidt MarianneEXECUTIVE OFFICER
EFSIEAGLE FINANCIAL SERVICES INC
Open-market sale
SELL$15K
388 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

25
Lizzie FletcherDSelf
JPMJPMORGAN CHASE & CO
Partial sale
SELL$1,001 – $15KApr 8, 2026May 1, 2026
traded Apr 8, 2026
+23dHouse PTR

Evidence

25
Lizzie FletcherDSelf
AMPAMERIPRISE FINANCIAL INC
Partial sale
SELL$1,001 – $15KApr 8, 2026May 1, 2026
traded Apr 8, 2026
+23dHouse PTR

Evidence

24
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$932K
12.8K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

24
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$628K
8,777 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

23
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
440 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

23
SM
Stetz MattiasChief Operating Officer
RSIRush Street Interactive, Inc.
Open-market sale · 10b5-1 plan
SELL$562K
20.0K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

22
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$30K
400 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

22
PR
Palmer Stephen RVice President of Accounting
CVNACARVANA CO.
Open-market sale · 10b5-1 plan
SELL$395K
1,000 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

20
Lizzie FletcherDSelf
KLACKLA CORP
Partial sale
SELL$1,001 – $15KApr 8, 2026May 1, 2026
traded Apr 8, 2026
+23dHouse PTR

Evidence

20
Lizzie FletcherDSelf
MCKMCKESSON CORP
Partial sale
SELL$1,001 – $15KApr 8, 2026May 1, 2026
traded Apr 8, 2026
+23dHouse PTR

Evidence

20
BL
Burrows Scott LChief Financial Officer
SYRESpyre Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$892K
12.5K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

20
Lizzie FletcherDSelf
PWRQUANTA SERVICES, INC.
Partial sale
SELL$1,001 – $15KApr 8, 2026May 1, 2026
traded Apr 8, 2026
+23dHouse PTR

Evidence